We performed a retrospective analysis of the electrocardiograms ( ECGs ) recorded at baseline and after 2 years for the first 1,004 type 2 diabetic individuals to be randomized in the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes ( RECORD ) study .
